What is the appropriate workup and management for galactorrhea in a non‑pregnant, non‑lactating patient?

Workup and Management of Galactorrhea

For a non-pregnant, non-lactating patient with galactorrhea, measure serum prolactin, TSH, and obtain a pregnancy test; if prolactin is elevated and medication-induced causes are excluded, obtain pituitary MRI and treat symptomatic prolactinomas with cabergoline as first-line therapy. 1

Initial Diagnostic Workup

Laboratory Testing

• Single serum prolactin measurement is sufficient to establish hyperprolactinemia—no dynamic testing needed 1

  • Draw at any time of day, avoiding excessive venipuncture stress
  • Normal values are assay-specific, generally <25 μg/L in women
  • Prolactin >250 μg/L strongly suggests prolactinoma
  • Prolactin >500 μg/L is diagnostic of macroprolactinoma 1

• Pregnancy test for all premenopausal women 2

• TSH level to exclude hypothyroidism 2, 3

• Renal function (creatinine) to exclude chronic kidney disease 2, 3

Medication Review

Immediately review all medications, as drug-induced hyperprolactinemia is the most common non-tumoral cause 1:

• High-risk medications: Antipsychotics (risperidone causes hyperprolactinemia in 40-90% of patients), metoclopramide, phenothiazines
• These can elevate prolactin to >200 μg/L, mimicking prolactinomas 1
• Prolactin takes 3 days to normalize after drug discontinuation 1

Imaging

Obtain pituitary MRI if 1:

• Prolactin is elevated AND no medication cause identified
• Medication-induced hyperprolactinemia suspected BUT onset doesn't coincide with drug initiation
• Any prolactin elevation with unclear etiology after lab workup

Management Algorithm

1. Medication-Induced Galactorrhea

If asymptomatic: No treatment needed 1

If symptomatic (amenorrhea, sexual dysfunction, bone loss concerns):

• First step: Discontinue offending medication if clinically feasible 1
• Second step: Substitute with alternative agent that doesn't cause hyperprolactinemia 1
• Third step: If neither option possible, consider cautious dopamine agonist therapy in consultation with prescribing physician 1
  • Critical caveat: In antipsychotic-induced hyperprolactinemia, dopamine agonists may exacerbate underlying psychosis 1

For long-term hypogonadism (hypogonadal symptoms or low bone mass): Consider estrogen or testosterone replacement if drug cannot be stopped 1

2. Prolactinoma-Related Galactorrhea

Symptomatic Microadenomas or Any Macroadenoma

Strongly recommend cabergoline as first-line therapy 1:

• Superior efficacy: normalizes prolactin in 92-95% of patients 1
• Resolves galactorrhea in 86% of cases 1
• Better tumor shrinkage (90% reduction vs 50% with bromocriptine) 1
• Better tolerated with fewer side effects 1
• Typical dosing: 0.25-3 mg/week (occasionally up to 11 mg/week) 1

Monitoring after starting cabergoline 1:

• Prolactin level at 1 month, then periodically to guide dose titration
• Repeat MRI at 1 year (or 3 months for macroadenomas)
• Visual field testing for macroadenomas near optic chiasm
• Assess bone density if prior hypogonadism

Asymptomatic Microadenomas

Do not treat with dopamine agonists 1—microadenomas rarely grow and observation is appropriate.

Alternative for premenopausal women with amenorrhea: Oral contraceptives are acceptable instead of dopamine agonists 1:

• Less expensive, fewer side effects
• No evidence that estrogen increases microadenoma growth over 2 years 1
• Caveat: Amenorrhea cannot be used to monitor for hyperprolactinemia recurrence on OCPs

3. Normal Prolactin with Galactorrhea

If prolactin and TSH are normal and galactorrhea is not bothersome: Reassurance only, no treatment needed 3

If bothersome: Short course of low-dose dopamine agonist usually effective 3

Common Pitfalls to Avoid

1. Don't order dynamic prolactin testing (TRH stimulation, etc.)—single measurement suffices 1

2. Don't assume high prolactin always means prolactinoma—risperidone and metoclopramide can cause levels >200 μg/L without adenoma 1

3. Don't forget the 3-day rule—wait 3 days after stopping medication before rechecking prolactin 1

4. Don't use dopamine agonists in asymptomatic medication-induced hyperprolactinemia—risk outweighs benefit, especially with antipsychotics 1

5. Don't use bromocriptine when cabergoline is available—cabergoline has definitively superior efficacy and tolerability 1